GlassScriptPhysician profile
Brian G Kauth
NPI 1780797803
$1,000.81
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $226 · 2020: $262 · 2021: $199 · 2023: $228 · 2024: $85.88.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $314.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $313.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $128.70 | 2020-2021 | |
| Glaxosmithkline, LLC. | $116.57 | 2019-2020 | |
| Abbvie INC. | $112.80 | 2020-2023 | |
| Gilead Sciences, INC. | $92.97 | 2019-2023 | |
| Pfizer INC. | $90.42 | 2019-2023 | |
| Supernus Pharmaceuticals, INC. | $87.82 | 2019-2021 | |
| Novo Nordisk INC | $66.38 | 2023-2024 | Wegovy, Ozempic, Rybelsus |
| Abbott Laboratories | $48.96 | 2023-2024 | Freestyle Libre 3 |
| Allergan, INC. | $42.19 | 2020 | |
| Inari Medical, INC. | $29.27 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Novartis Pharmaceuticals Corporation | $25.44 | 2019-2020 | |
| Nestle Healthcare Nutrition INC. | $23.94 | 2020-2021 | |
| Mannkind Corporation | $22.56 | 2023 | Afrezza |
| Amgen INC. | $21.53 | 2024 | Krystexxa |
| Genentech USA, INC. | $15.27 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $14.88 | 2024 | Jardiance, Zepbound |
| Astrazeneca Pharmaceuticals LP | $13.26 | 2019 | |
| Phathom Pharmaceuticals, INC. | $13.11 | 2024 | Voquezna |
| Takeda Pharmaceuticals U.S.A., INC. | $12.51 | 2020 | |
| Astellas Pharma US INC | $11.39 | 2019 | |
| Merck Sharp & Dohme LLC | $10.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Kauth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.